Wordt geladen...
Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation
BACKGROUND: Agonists of 5‐hydroxytryptamine 4 receptor are potential agents for irritable bowel syndrome with predominant constipation (IBS‐C). However, only tegaserod has been approved for a very limited population in the US. AIM: To evaluate the efficacy and safety of minesapride in patients with...
Bewaard in:
| Gepubliceerd in: | Aliment Pharmacol Ther |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7383621/ https://ncbi.nlm.nih.gov/pubmed/32583907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15907 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|